Scripps-Palo Alto Research Center Institute Unveils Technology To Accelerate The Discovery Of Breakthrough Drugs
10/19/2005 5:11:35 PM
The Scripps-PARC Institute for Advanced Biomedical Sciences, a joint venture of the Palo Alto Research Center (PARC) and The Scripps Research Institute, today announced a technology capable of significantly improving drug discovery. The newly developed nanocalorimeter will enable researchers to measure the level and nature of chemical activity of pharmaceutical prototypes with unparalleled accuracy and speed. This improved clarity will have substantial impact on the cost of drug development by drastically reducing the level of effort required in new drug design. These advancements will allow pharmaceutical companies to reduce the time to market of drug treatments while reducing research and development investments that can inhibit wide-scale consumer access.
comments powered by